Skip to main content
Erschienen in: Annals of Nuclear Medicine 10/2011

01.12.2011 | Original article

Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study

verfasst von: Kazuo Kubota, Koji Murakami, Tomio Inoue, Tsuneo Saga, Susumu Shiomi

Erschienen in: Annals of Nuclear Medicine | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study was a controlled multicenter clinical study on patients with peripheral lung nodules to verify the improvement in the diagnostic ability of FDG-PET when used in combination with thin-section CT (TS-CT).

Methods

Patients with peripheral lung nodules (long maximal diameter: 10–30 mm) detected using CT were examined using TS-CT and FDG-PET for the differential diagnosis of benign or malignant lesions. The primary endpoint was the specificity of the results using a combination of TS-CT and FDG-PET, compared with the results for TS-CT alone. Images were interpreted by investigators at each institution. Blind readings were also performed by an independent image interpretation committee. The gold standard was a pathological diagnosis determined using a surgical or biopsy specimen obtained after PET; and the patients in whom a pathological diagnosis could not be obtained were diagnosed based on a follow-up TS-CT performed more than 6 months later. Adverse reactions to FDG were also evaluated.

Results

The blind reading results for 82 lesions in 81 subjects eligible for analysis among the 90 subjects included in the study showed a specificity of 91.2% (31/34) (95% CI: 76.3–98.1) for TS-CT + PET, compared with a specificity of 67.6% (23/34) (95% CI: 49.5–82.6) for TS-CT alone. The specificity was significantly improved by the addition of the PET findings (p < 0.05). The sensitivity improved from 89.6% (43/48) for TS-CT to 91.7% (44/48) for TS-CT + PET; the addition of PET increased the level of confidence in the diagnosis, but the difference was not significant. The results reported by the institutional investigators were not significantly different. No serious adverse reactions occurred, although two of the 90 subjects exhibited mild adverse reactions.

Conclusions

The addition of FDG-PET to TS-CT for the differential diagnosis of benign or malignant peripheral lung nodules resulted in a significant improvement in specificity. Although a definitive diagnosis of lung nodules requires a histopathological or cytological examination, when combined with TS-CT, FDG-PET can provide additional diagnostic information and improve the specificity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat The Japan Lung Cancer Society. Lung cancer clinical practice guidelines by the EBM approach. Kanehara Shuppan, Japan; 2010. The Japan Lung Cancer Society. Lung cancer clinical practice guidelines by the EBM approach. Kanehara Shuppan, Japan; 2010.
2.
Zurück zum Zitat Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914–24.PubMedCrossRef Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914–24.PubMedCrossRef
3.
Zurück zum Zitat Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–8.PubMed Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–8.PubMed
4.
Zurück zum Zitat Imdahl A, Jenkner S, Brink I, Nitzsche E, Stoelben E, Moser E, et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg. 2001;20:324–9.PubMedCrossRef Imdahl A, Jenkner S, Brink I, Nitzsche E, Stoelben E, Moser E, et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg. 2001;20:324–9.PubMedCrossRef
5.
Zurück zum Zitat Präuer HW, Weber WA, Römer W, Treumann T, Ziegler SI, Schwaiger M. Controlled prospective study of positron emission tomography using the glucose analogue [18F]Fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg. 1998;85:1506–11.PubMedCrossRef Präuer HW, Weber WA, Römer W, Treumann T, Ziegler SI, Schwaiger M. Controlled prospective study of positron emission tomography using the glucose analogue [18F]Fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg. 1998;85:1506–11.PubMedCrossRef
6.
Zurück zum Zitat Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–84.PubMed Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–84.PubMed
7.
Zurück zum Zitat Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943–8.PubMed Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37:943–8.PubMed
8.
Zurück zum Zitat Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med. 1996;153:417–21.PubMed Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med. 1996;153:417–21.PubMed
9.
Zurück zum Zitat Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol. 2006;187:1361–7.PubMedCrossRef Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol. 2006;187:1361–7.PubMedCrossRef
10.
Zurück zum Zitat Schillaci O, Travascio L, Bolacchi F, Calabria F, Bruni C, Cicciò C, et al. Accuracy of early and delayed FDG PET–CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med. 2009;114:890–906.PubMedCrossRef Schillaci O, Travascio L, Bolacchi F, Calabria F, Bruni C, Cicciò C, et al. Accuracy of early and delayed FDG PET–CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients. Radiol Med. 2009;114:890–906.PubMedCrossRef
11.
Zurück zum Zitat FDA guidance for industry developing medical imaging drugs and biological products. Part 3: Design, analysis, and interpretation of clinical studies; 2004. FDA guidance for industry developing medical imaging drugs and biological products. Part 3: Design, analysis, and interpretation of clinical studies; 2004.
12.
Zurück zum Zitat Guidelines on clinical evaluation of radioactive diagnostics. Japanese Society of Nuclear Medicine, Japan; 2005. Guidelines on clinical evaluation of radioactive diagnostics. Japanese Society of Nuclear Medicine, Japan; 2005.
Metadaten
Titel
Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study
verfasst von
Kazuo Kubota
Koji Murakami
Tomio Inoue
Tsuneo Saga
Susumu Shiomi
Publikationsdatum
01.12.2011
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 10/2011
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-011-0528-5

Weitere Artikel der Ausgabe 10/2011

Annals of Nuclear Medicine 10/2011 Zur Ausgabe